This study illustrates the healthcare utilization patterns, direct costs, and sustained virologic response rates associated with interferon-based therapies for hepatitis C patients.
Titilope Adeniyi, MS
Advertisement
Articles by Titilope Adeniyi, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves XFG-Adapted COVID-19 Vaccine, mRNA for the 2026-2027 Season
2
Beyond the Transplant Center: IV Therapy in the Community
3
Incorporating Patient-Reported Symptoms into Treatment Plans
4
Safety Monitoring Protocols During Transitions of Care
5